跳至主要内容
临床试验/NCT05486455
NCT05486455招募中不适用

Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers: a "Real Life" Study

Hospital St. Joseph, Marseille, France1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2022年11月4日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000
试验地点
1
主要终点
Positive Predictive Value (PPV)

研究概览

简要总结

Diagnostic performance of low-dose chest CT scan combined with lung-RADS classification (version 1.1) for lung cancer screening among former and current smokers.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female 50-80 years old
  • Active smoker (≥ 15 PA) or former smoker (≥ 15 PA)

排除标准

  • Recent history of chest CT scan (within 12 months)
  • Person unable to climb 2 floors
  • Weight > 140kg
  • Personal history of cancer < 5 years (currently being monitored by thoracic imaging)

结局指标

主要结局

Positive Predictive Value (PPV)

时间窗: 5 years

次要结局

  • Penetration rate(5 years)
  • 5-year survival rate of patients who have undergone thoracic surgery(5 years)
  • Risk ratio of lung cancer(5 years)
  • Early stage lung cancer detection rate (stage I and II)(5 years)
  • Number of false positive results(5 years)
  • Specificity(5 years)
  • Sensitivity(5 years)
  • Rate of smoking-related co-morbidities detected on low-dose CT scan(5 years)
  • Rate of additional examinations (including invasive diagnostic tests and surgery with benign results)(5 years)
  • Smoking cessation rates(5 years)
  • EORTC QLQ-C30 score (version 3)(5 years)

研究者

发起方
Hospital St. Joseph, Marseille, France
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验